The Life Science segment of Germany’s Merck is investing around €440 million to increase membrane and filtration manufacturing capabilities in Ireland’s County Cork. The...

Germany’s Merck has signed has an agreement with the Administrative Management Committee of Wuxi National High-Tech Industrial Development Zone to “significantly expand”...

Germany’s Merck has acquired Lonza’s Modular Automated Sampling Technology (MAST) platform for an undisclosed sum. The Darmstadt-based chemicals, pharmaceuticals and life...

Germany’s Merck has completed the acquisition of US biopharmaceutical CDMO Exelead for $780 million in cash following the fulfillment of all closing conditions. The...

German pharmaceuticals, chemicals and life sciences group Merck has restructured its life science business to promote growth and to better cater to the needs of an...

Germany’s Merck has signed a definitive agreement to acquire Exelead, a US biopharmaceutical CDMO, for around $780 million in cash. The Indianapolis, Indiana-based...

The Life Science business segment of Germany’s Merck has won a €121 million US government contract to build a new plant for its “Hi-Flow" Plus lateral flow membranes used...

Germany’s Merck is allocating an additional €600 million to its strategic corporate venture capital arm M Ventures. The chemicals, pharmaceuticals and life sciences group...